Full Text View
Tabular View
No Study Results Posted
Related Studies
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
This study is currently recruiting participants.
Study NCT00833248   Information provided by Ferring Pharmaceuticals
First Received: January 30, 2009   Last Updated: October 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Degarelix
Additional drug interventions recognized in this trial
Androgen Antagonists
Androgens
Bicalutamide
Goserelin
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Ferring Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services